Eritoran attenuates tissue damage and inflammation in hemorrhagic shock/trauma
- 1 October 2013
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 184 (2) , e17-e25
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- In Vivo Toll-Like Receptor 4 Antagonism Restores Cardiac Function During EndotoxemiaShock, 2011
- From agonist to antagonist: Structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxinsMolecular Immunology, 2011
- Trauma Hemorrhagic Shock-Induced Lung Injury Involves a Gut-Lymph-Induced TLR4 Pathway in MicePLOS ONE, 2011
- Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesExpert Opinion on Drug Metabolism & Toxicology, 2011
- Systemic Inflammation and Liver Injury Following Hemorrhagic Shock and Peripheral Tissue Trauma Involve Functional TLR9 Signaling on Bone Marrow-Derived Cells and Parenchymal CellsShock, 2011
- TLR Cross-Talk Mechanism of Hemorrhagic Shock-Primed Pulmonary Neutrophil InfiltrationThe Open Critical Care Medicine Journal, 2009
- LOCAL EXPOSURE OF BONE COMPONENTS TO INJURED SOFT TISSUE INDUCES TOLL-LIKE RECEPTOR 4-DEPENDENT SYSTEMIC INFLAMMATION WITH ACUTE LUNG INJURYShock, 2008
- HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signalingJournal of Experimental Medicine, 2007
- Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophagesJournal of Experimental Medicine, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004